These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 9000671)

  • 1. Lack of cognate help by CD4+ T cells and anergy of CD8+ T cells are the principal mechanisms for anti-leukocyte function-associated antigen-1/intercellular adhesion molecule-1-induced cardiac allograft tolerance.
    Bashuda H; Seino K; Ra C; Yagita H; Okumura K
    Transplantation; 1997 Jan; 63(1):113-8. PubMed ID: 9000671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
    Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
    J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of anti-intercellular adhesion molecule-1 and anti-leukocyte function associated antigen-1 monoclonal antibodies on rat-to-mouse cardiac xenograft rejection.
    Miwa S; Isobe M; Suzuki J; Makuuchi M; Miyasaka M; Yamazaki S; Kawasaki S
    Surgery; 1997 Jun; 121(6):681-9. PubMed ID: 9186469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of persistent allograft tolerance in the rat by combined treatment with anti-leukocyte function-associated antigen-1 and anti-intercellular adhesion molecule-1 monoclonal antibodies, donor-specific transfusion, and FK506.
    Bashuda H; Takazawa K; Tamatani T; Miyasaka M; Yagita H; Okumura K
    Transplantation; 1996 Jul; 62(1):117-22. PubMed ID: 8693525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients.
    Hamano K; Rawsthorne MA; Bushell AR; Morris PJ; Wood KJ
    Transplantation; 1996 Sep; 62(6):856-60. PubMed ID: 8824489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
    Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
    Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific acceptance of fetal bowel allograft in mice after combined treatment with anti-intercellular adhesion molecule-1 and leukocyte function-associated antigen-1 antibodies.
    Kato Y; Yamataka A; Yagita H; Okumura K; Fujiwara T; Miyano T
    Ann Surg; 1996 Jan; 223(1):94-100. PubMed ID: 8554424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression.
    Wong W; Morris PJ; Wood KJ
    Transplantation; 1997 May; 63(10):1490-4. PubMed ID: 9175815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Awareness of donor alloantigens in antiadhesion therapy induces antigen-specific unresponsiveness to islet allografts.
    Nishihara M; Gotoh M; Ohzato H; Ohta Y; Luo Z; Dono K; Umeshita K; Sakon M; Monden M; Yagita H; Okumura K; Miyasaka M
    Transplantation; 1997 Oct; 64(7):965-70. PubMed ID: 9381542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
    Arima T; Lehmann M; Flye MW
    Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation by differential development of Th1 and Th2 cells in peripheral tolerance to cardiac allograft induced by blocking ICAM-1/LFA-1 adhesion.
    Isobe M; Suzuki J; Yamazaki S; Yazaki Y; Horie S; Okubo Y; Maemura K; Yazaki Y; Sekiguchi M
    Circulation; 1997 Oct; 96(7):2247-53. PubMed ID: 9337197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression by inhibition of cellular adhesion mediated by leukocyte function-associated antigen-1/intercellular adhesion molecule-1 in murine cardiac transplantation.
    Xu XY; Honjo K; Devore-Carter D; Bucy RP
    Transplantation; 1997 Mar; 63(6):876-85. PubMed ID: 9089229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of tolerance induction to cardiac allograft by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies.
    Isobe M; Suzuki J; Yamazaki S; Horie S; Okubo Y; Sekiguchi M
    J Heart Lung Transplant; 1997 Nov; 16(11):1149-56. PubMed ID: 9402515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of alloantigen-reactive thymocytes as a mechanism of adult tolerance induction following intrathymic antigen administration.
    Jones ND; Fluck NC; Roelen DL; Mellor AL; Morris PJ; Wood KJ
    Eur J Immunol; 1997 Jul; 27(7):1591-600. PubMed ID: 9247566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells. Implications for cellular and humoral responses.
    Bishop DK; Li W; Chan SY; Ensley RD; Shelby J; Eichwald EJ
    Transplantation; 1994 Sep; 58(5):576-84. PubMed ID: 7522364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
    Cong L; Wang SF; Zhao ZL; Yang RY
    Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y; Tang XD; Zhou PJ
    Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
    Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
    J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.